Trials and Therapy Archives

Home › Thrombosis and cancer › Trials and Therapy

Development, evaluation, and validation of an innovative electronic clinical risk prediction model for CAT

Thromboprophylaxis remains a critical concern in cancer patients initiating chemotherapy due to their heightened risk...

Atrial fibrillation (AF) is common in patients with cancer, and up to one in every four persons with AF has comorbid...

During the ICTHIC webinar, “Long-term treatment & DDI implications in the management of CAT,” Dr. Tzu-Fei Wang...

During the ICTHIC webinar, “Updates in cancer-associated thrombosis,” Dr. Luis Jara-Palomares gave a lecture on the...

During the ICTHIC webinar, “Long-term treatment & DDI implications in the management of CAT,” Dr. Luis...

Gastrointestinal (GI) cancers represent 26% of the global cancer incidence and more than one-third of all...

Recurrent venous thromboembolism (VTE) and major bleeding are the two major challenges in managing cancer-associated...

During the ICTHIC webinar “Clinical insights in CAT to include COVID‐19“, prof Andrez Muñoz shared data...

Cancer-associated thrombosis management is incredibly challenging because of the high risk of recurrence and severe...

During the 10th ICTHIC, Prof. Jeffrey Zwicker (Harvard Medical School, MA, USA) gave an overview of the evidence of the...